Capital International Inc. CA Purchases 8,101 Shares of Kenvue Inc. (NYSE:KVUE)

Capital International Inc. CA grew its position in Kenvue Inc. (NYSE:KVUE) by 3.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 213,858 shares of the company’s stock after acquiring an additional 8,101 shares during the period. Capital International Inc. CA’s holdings in Kenvue were worth $4,589,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Stephens Inc. AR increased its position in Kenvue by 86.1% during the fourth quarter. Stephens Inc. AR now owns 57,694 shares of the company’s stock worth $1,242,000 after acquiring an additional 26,700 shares during the period. Stifel Financial Corp increased its holdings in Kenvue by 60.4% in the 4th quarter. Stifel Financial Corp now owns 745,064 shares of the company’s stock valued at $16,041,000 after buying an additional 280,591 shares during the period. Raleigh Capital Management Inc. increased its holdings in Kenvue by 93,834.8% in the 4th quarter. Raleigh Capital Management Inc. now owns 43,210 shares of the company’s stock valued at $930,000 after buying an additional 43,164 shares during the period. Fifth Third Bancorp increased its holdings in Kenvue by 35.3% in the 4th quarter. Fifth Third Bancorp now owns 277,580 shares of the company’s stock valued at $5,976,000 after buying an additional 72,435 shares during the period. Finally, The Manufacturers Life Insurance Company increased its holdings in Kenvue by 2.6% in the 4th quarter. The Manufacturers Life Insurance Company now owns 1,598,567 shares of the company’s stock valued at $34,417,000 after buying an additional 40,995 shares during the period. Institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have commented on KVUE. HSBC raised their target price on shares of Kenvue from $20.00 to $21.00 and gave the company a “hold” rating in a report on Wednesday, May 8th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Kenvue from $24.00 to $23.00 and set a “buy” rating on the stock in a report on Thursday. Citigroup decreased their target price on shares of Kenvue from $21.00 to $20.00 and set a “neutral” rating on the stock in a report on Wednesday, July 10th. William Blair initiated coverage on shares of Kenvue in a report on Wednesday, April 3rd. They issued a “market perform” rating on the stock. Finally, Sanford C. Bernstein initiated coverage on shares of Kenvue in a report on Thursday, April 11th. They set an “underperform” rating and a $18.00 price target on the stock. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $22.45.

Kenvue Trading Up 2.4 %

NYSE:KVUE traded up $0.44 during mid-day trading on Friday, hitting $18.69. 11,484,071 shares of the company’s stock were exchanged, compared to its average volume of 19,043,316. The company has a 50 day simple moving average of $18.59 and a 200-day simple moving average of $19.56. The company has a current ratio of 0.99, a quick ratio of 0.68 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $25.00. The firm has a market capitalization of $35.79 billion, a P/E ratio of 23.96, a PEG ratio of 1.99 and a beta of 1.40.

Kenvue (NYSE:KVUE) last posted its earnings results on Tuesday, May 7th. The company reported $0.28 EPS for the quarter, topping the consensus estimate of $0.25 by $0.03. Kenvue had a net margin of 9.63% and a return on equity of 21.06%. The business had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $3.79 billion. The firm’s quarterly revenue was down 24.9% on a year-over-year basis. As a group, research analysts expect that Kenvue Inc. will post 1.13 earnings per share for the current year.

Kenvue Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 28th. Investors of record on Wednesday, August 14th will be given a dividend of $0.205 per share. The ex-dividend date of this dividend is Wednesday, August 14th. This is an increase from Kenvue’s previous quarterly dividend of $0.20. This represents a $0.82 annualized dividend and a yield of 4.39%. Kenvue’s dividend payout ratio (DPR) is currently 102.56%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.